Objective: Fear of cancer recurrence (FCR) is common, debilitating, and costly to the health system. While there has been a rising trajectory in FCR-related research, there remain many unanswered questions. A research agenda is required to clarify priorities and ensure that research dollars and effort are expended wisely. This study aimed to elicit research topics and priorities from clinical and academic experts in FCR.
| INTRODUCTION
Fear of cancer recurrence (FCR), defined as "fear, worry or concern relating to the possibility that cancer will come back or progress," 1(p3266) is pervasive among cancer survivors. While some degree of FCR among cancer survivors is considered normal, 1 approximately 50% experience moderate to high FCR levels. 2 High FCR does not appear to diminish over time and is associated with greater psychological distress, impaired quality of life, and increased health care utilisation. 2 While FCR overlaps with other forms of psychological distress, FCR is often an isolated focus of worry in otherwise mentally well individuals. 3 Up to 79% of survivors report an unmet need for help dealing with FCR; it is the most commonly reported unmet need in most studies. 2 In response to this demonstrated need, research in the field of FCR has increased dramatically in the past 8 years. A MEDLINE search using the term "fear of cancer recurrence" reveals that prior to 2010, there were 26 published papers (the first published in 1981). 4 In contrast, there have been an additional 139 publications in the period 2011-2018, 34 in 2017 alone. Recent activity has focused on defining FCR (particularly clinically significant FCR), 1, 5 advancing theoretical formulations of FCR, 6, 7 screening for and assessing FCR, 8 and developing and evaluating interventions for FCR, [9] [10] [11] a number of which have demonstrated efficacy, maintained at 6-or 12-month follow-up. [9] [10] [11] Nonetheless, there remain many unaddressed issues that require further research to guide effective management and care of people experiencing moderate to high FCR. Setting a clear research agenda would move the field forward. Research agendas are useful to help individual researchers and research institutions (1) understand how they can contribute to a greater body of knowledge and (2) find their place in the field or role in the larger research picture. Once created, a FCR research agenda is an invitation to individuals and institutions to engage in research that will strategically serve the field of FCR and contribute to reducing FCR.
Thus, the aims of this study were to elicit from Australian researchers and clinicians with expertise in FCR, their views on research priorities in FCR, and to establish consensus regarding the research priorities, which should be addressed in the next 5 years.
| METHODS AND RESULTS: PHASE 1 (IDENTIFYING RESEARCH TOPICS)
A mixed-methods design combining quantitative (survey) data (step 1) with a qualitative focus group (step 2) was used to elicit research topics from stakeholders.
| Step 1 (survey)
The PoCoG-a national cancer clinical trials group-has a multidisci- An additional 13 research areas were identified during the focus group. The total pool of topics was therefore 27 (see Table 2 ), falling under four overarching themes: (1) intervention models; (2) reaching specific populations; (3) definition, predictors, and outcomes of FCR;
and (4) detection and screening.
| METHODS, PHASE 2: GAINING CONSENSUS ON RESEARCH PRIORITIES
An online Delphi process, incorporating two rounds of feedback, was conducted to gain consensus on which aspects of FCR research should take priority as part of a comprehensive research agenda. We followed the reporting standard for Conducting and REporting of DElphi Studies (CREDES). 
| Delphi process
The Delphi technique, a well-recognised tool for establishing research priorities, 15, 16 is a series of sequential questionnaires or "rounds,"
interspersed by controlled feedback (a summary of results from the previous round), to gain reliable consensus of opinion of an "expert panel." 17 At round 1, panellists rated the importance of the 27 research priorities on a 5-point Likert scale (1, very important, to 5, not important at all) and commented on their rationale for ratings.
Consensus was defined as 80% or more of respondents rating the topic within two points. 18 Data were summarised and used to formulate round 2. In round 2, participants rerated topics that had failed to reach consensus (n = 6), in light of experts' comments, plus additional priorities generated in round 1 (n = 2). Panellists also ranked five overarching research themes on a scale from 1 (highest priority) to 5. Note that after analysis of participant comments, four topics (numbers [7] [8] [9] [10] originally under the first theme, intervention models, were placed in a new theme (training for health professionals) for clarity at this stage.
Nonresponders (n = 8) were emailed up to three reminders over 3 weeks for each round. As sufficient consensus was reached at the end of round 2, further rounds were not conducted.
The study was approved by The University of Sydney Ethics
Committee (approval number 2018/574). place of residence, and discipline (see Table 1 ).
| Data analysis
Twenty-seven topics were presented in round 1, and 21 of these reached consensus. The remaining six topics were included in round 2, plus two topics suggested by participants in round 1. In round 2, consensus was reached on one topic, and on three topics there was near to consensus (>78% agreement); these topics were retained, providing 25 ratified topics in total. 
| Reaching specific populations
Participants noted the importance of reaching specific populations with the greatest need. These included patients diagnosed with a second primary cancer; males (given that most FCR research has been conducted with female breast cancer patients); patients with multimorbidities (where cancer may be only one of several diseases with which patients are grappling); patients with chronic or nonstaged cancers such as haematological and ovarian cancer patients (where 
| Detection and screening
Participants stated there were issues with FCR measurement tools that still needed resolving, including optimal length of instrument and timing of screening. They noted that FCR is sometimes transient, resolving naturally, and they felt it was important to distinguish this from FCR requiring intervention. Participants also acknowledged that patients receiving surgery only often "fell through the cracks." They identified several other hard-to-reach populations, such as patients from regional, rural, and remote areas and migrants who may miss out on screening. Innovative ways to reach these populations were perceived as important.
| Ranking research priorities
The mean ranking of overarching themes is shown in Table 3 . Intervention models ranked as the highest priority (mean rank = 2.5) with reaching specific populations ranking lowest (mean rank = 3.68).
| DISCUSSION
In this research prioritisation exercise, we identified a comprehensive, Australian FCR research agenda that may have some relevance internationally, acknowledging that cultural variations in psycho-oncology training and resources may give rise to different priorities. We outlined research issues relevant to developing evidence-based, flexi- Health professional training in managing FCR was seen as important, although optimal therapist professional background is likely to vary from country to country. For example, in some countries and services, there is ready access to health professionals with training and expertise in the delivery of theoretically grounded, cognitive-behaviourally based interventions, such as psychologists and psychiatrists. In other jurisdictions, oncologists and/or nurses will most likely deliver FCR interventions. 26 Evidence to support intervention delivery within different models is essential to ensure care is delivered safely and effectively.
Suitable training to support interventionists, with or without psychosocial expertise, is required and needs to be widely accessible.
To truly influence policy and practice, there is no doubt that a better understanding of the costs and consequences of FCR for individuals, families, and society as a whole is needed. Economic A next step would be to conduct a similar Delphi study in the international context, which would build on research priorities established at an international symposium on FCR in 2015, 28 many of which have now been addressed. One issue for such a future study is to consider how to encourage greater diversity in ratings. Our sample rated most research areas highly (between 1 and 2). While FCR research is still in its infancy, and setting too tight a research agenda may not yet be warranted, the current findings demonstrate the urgency and breadth of research needed in this field, which might hopefully influence research funders to prioritise this area.
| Clinical implications
The current findings have potential to guide FCR researchers towards clinically relevant, significant research that will move the field forward.
Clearly, an intervention focus is favoured, but now exploring optimal formats of delivery, including stepped-care and blended models incorporating online elements, and targeted to specific populations, is a priority. 
